Given that HLA‐DR expression is often downregulated in DLBCL and linked to a poorer prognosis,38, 39, 40 the enrichment of HLADR+ CD8+ Tfr cells offers a unique insight into the regulatory landscape of the DLBCL TME. The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.